{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:13:21Z","timestamp":1783667601498,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,9]]},"DOI":"10.7759\/cureus.112380","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:24:55Z","timestamp":1783664695000},"source":"Crossref","is-referenced-by-count":0,"title":["Inpatient Hemato-Oncology Service Use Before, During, and After COVID-19 Restrictions in a Romanian Tertiary Center"],"prefix":"10.7759","author":[{"given":"Paul C","family":"Toboltoc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. (2020). Accessed: May 10, 2026: https:\/\/www.who.int\/news-room\/speeches\/item\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-...."},{"key":"ref2","unstructured":"Embassy of Romania in Washington. The quarantine measure for people arriving in Romania has been lifted. (2022). Accessed: May 10, 2026: https:\/\/washington.mae.ro\/en\/local-news\/2321."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/GO.20.00639","article-title":"Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review","volume":"7","author":"Riera R","year":"2021","unstructured":"Riera R, Bagattini \u00c2M, Pacheco RL, Pachito DV, Roitberg F, Ilbawi A. Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review. JCO Glob Oncol. 2021, 7:311-23. 10.1200\/GO.20.00639","journal-title":"JCO Glob Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-022-00946-6","article-title":"Decrease of cancer diagnosis during COVID-19 pandemic: a systematic review and meta-analysis","volume":"38","author":"Angelini M","year":"2023","unstructured":"Angelini M, Teglia F, Astolfi L, Casolari G, Boffetta P. Decrease of cancer diagnosis during COVID-19 pandemic: a systematic review and meta-analysis. Eur J Epidemiol. 2023, 38:31-8. 10.1007\/s10654-022-00946-6","journal-title":"Eur J Epidemiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020008824","article-title":"Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients","volume":"136","author":"Vijenthira A","year":"2020","unstructured":"Vijenthira A, Gong IY, Fox TA, et al.. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020, 136:2881-92. 10.1182\/blood.2020008824","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100403","article-title":"Managing hematological cancer patients during the COVID-19 pandemic: an\u00a0ESMO-EHA Interdisciplinary Expert Consensus","volume":"7","author":"Buske C","year":"2022","unstructured":"Buske C, Dreyling M, Alvarez-Larr\u00e1n A, et al.. Managing hematological cancer patients during the COVID-19 pandemic: an\u00a0ESMO-EHA Interdisciplinary Expert Consensus. ESMO Open. 2022, 7:100403. 10.1016\/j.esmoop.2022.100403","journal-title":"ESMO Open"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01439","article-title":"Management of patients with hematologic malignancies during the COVID-19 pandemic: practical considerations and lessons to be learned","volume":"10","author":"Isidori A","year":"2020","unstructured":"Isidori A, de Leval L, Gergis U, Musto P, Porcu P. Management of patients with hematologic malignancies during the COVID-19 pandemic: practical considerations and lessons to be learned. Front Oncol. 2020, 10:1439. 10.3389\/fonc.2020.01439","journal-title":"Front Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2340\/1651-226X.2024.35238","article-title":"Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival\u2009- a Swedish Lymphoma Register Study","volume":"63","author":"Ekberg S","year":"2024","unstructured":"Ekberg S, Molin D, Pahnke S, Bergstr\u00f6m F, Br\u00e5nvall E, Smedby KE, W\u00e4sterlid T. Impact of the COVID-19 pandemic on lymphoma incidence and short-term survival\u2009- a Swedish Lymphoma Register Study. Acta Oncol. 2024, 63:164-8. 10.2340\/1651-226X.2024.35238","journal-title":"Acta Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16782","article-title":"Assessing the impact of lockdown: fresh challenges for the care of haematology patients in the COVID-19 pandemic","volume":"189","author":"Willan J","year":"2020","unstructured":"Willan J, King AJ, Djebbari F, et al.. Assessing the impact of lockdown: fresh challenges for the care of haematology patients in the COVID-19 pandemic. Br J Haematol. 2020, 189:e224-7. 10.1111\/bjh.16782","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00795-w","article-title":"Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic","volume":"13","author":"Carmichael J","year":"2023","unstructured":"Carmichael J, Seymour F, McIlroy G, et al.. Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic. Blood Cancer J. 2023, 13:38. 10.1038\/s41408-023-00795-w","journal-title":"Blood Cancer J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00588-z","article-title":"Impact of COVID-19 in patients with multiple myeloma based on a global data network","volume":"11","author":"Martinez-Lopez J","year":"2021","unstructured":"Martinez-Lopez J, Hernandez-Ibarburu G, Alonso R, et al.. Impact of COVID-19 in patients with multiple myeloma based on a global data network. Blood Cancer J. 2021, 11:198. 10.1038\/s41408-021-00588-z","journal-title":"Blood Cancer J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13192520","article-title":"Impact of the COVID-19 pandemic on hemato-oncology services: a retrospective dual-center cohort study in Kazakhstan","volume":"13","author":"Yerdenova M","year":"2025","unstructured":"Yerdenova M, Izekenova A, Myrkassymova A, et al.. Impact of the COVID-19 pandemic on hemato-oncology services: a retrospective dual-center cohort study in Kazakhstan. Healthcare (Basel). 2025, 13:2520. 10.3390\/healthcare13192520","journal-title":"Healthcare (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.currproblcancer.2022.100913","article-title":"Diagnosis and management of classical Hodgkin lymphoma during the COVID-19 pandemic","volume":"46","author":"K\u00fc\u00e7\u00fckyurt S","year":"2022","unstructured":"K\u00fc\u00e7\u00fckyurt S, \u015eahin K, Y\u0131lmaz U, et al.. Diagnosis and management of classical Hodgkin lymphoma during the COVID-19 pandemic. Curr Probl Cancer. 2022, 46:100913. 10.1016\/j.currproblcancer.2022.100913","journal-title":"Curr Probl Cancer"},{"key":"ref14","unstructured":"Romanian National Institute of Statistics. TEMPO-Online resident-population series. (2026). Accessed: May 2, 2026: http:\/\/statistici.insse.ro\/tempoins\/index.jsp."},{"key":"ref15","unstructured":"STROBE. Strengthening the reporting of observational studies in epidemiology. (2026). Accessed: July 8, 2026: https:\/\/www.strobe-statement.org\/."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100197","article-title":"Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis","volume":"6","author":"Peacock HM","year":"2021","unstructured":"Peacock HM, Tambuyzer T, Verdoodt F, et al.. Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis. ESMO Open. 2021, 6:100197. 10.1016\/j.esmoop.2021.100197","journal-title":"ESMO Open"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2340\/1651-226X.2025.42079","article-title":"Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries","volume":"64","author":"Johansson A","year":"2025","unstructured":"Johansson A, Skog A, Johannesen TB, et al.. Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries. Acta Oncol. 2025, 64:257-66. 10.2340\/1651-226X.2025.42079","journal-title":"Acta Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djad086","article-title":"Interpreting cancer incidence trends: challenges due to the COVID-19 pandemic","volume":"115","author":"Mariotto AB","year":"2023","unstructured":"Mariotto AB, Feuer EJ, Howlader N, Chen HS, Negoita S, Cronin KA. Interpreting cancer incidence trends: challenges due to the COVID-19 pandemic. J Natl Cancer Inst. 2023, 115:1109-11. 10.1093\/jnci\/djad086","journal-title":"J Natl Cancer Inst"},{"key":"ref19","article-title":"COVID-19 impact on cancer incidence in Ireland in 2021: a preliminary analysis","year":"2023","unstructured":"COVID-19 Impact on Cancer Incidence in Ireland in 2021. A Preliminary Analysis. National Cancer Registry Ireland, Cork, Ireland; 2023. https:\/\/www.ncri.ie\/en\/reports-publications\/reports\/covid-19-impact-on-cancer-incidence-in-ireland-in-2021-a-preliminary."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1230289","article-title":"Decrease in the number of new cancer diagnoses during the first year of the COVID-19 pandemic - cohort study of 3.5 million individuals in western Poland","volume":"13","author":"Trojanowski M","year":"2023","unstructured":"Trojanowski M, Radomyski P, Kycler W, Michalek IM. Decrease in the number of new cancer diagnoses during the first year of the COVID-19 pandemic - cohort study of 3.5 million individuals in western Poland. Front Oncol. 2023, 13:1230289. 10.3389\/fonc.2023.1230289","journal-title":"Front Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-021-01472-0","article-title":"Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: a population-based study","volume":"125","author":"Hamilton AC","year":"2021","unstructured":"Hamilton AC, Donnelly DW, Loughrey MB, et al.. Inequalities in the decline and recovery of pathological cancer diagnoses during the first six months of the COVID-19 pandemic: a population-based study. Br J Cancer. 2021, 125:798-805. 10.1038\/s41416-021-01472-0","journal-title":"Br J Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133215","article-title":"Significant decrease in annual cancer diagnoses in Spain during the COVID-19 pandemic: a real-data study","volume":"13","author":"Ruiz-Medina S","year":"2021","unstructured":"Ruiz-Medina S, Gil S, Jimenez B, et al.. Significant decrease in annual cancer diagnoses in Spain during the COVID-19 pandemic: a real-data study. Cancers (Basel). 2021, 13:3215. 10.3390\/cancers13133215","journal-title":"Cancers (Basel)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-04707-0","article-title":"Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany","volume":"149","author":"Voigtl\u00e4nder S","year":"2023","unstructured":"Voigtl\u00e4nder S, Hakimhashemi A, Grundmann N, et al.. Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany. J Cancer Res Clin Oncol. 2023, 149:7493-503. 10.1007\/s00432-023-04707-0","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061753","article-title":"Impact of the COVID-19 pandemic on cancer diagnosis in Madrid (Spain) based on the RTMAD Tumor Registry (2019-2021)","volume":"15","author":"Garrido-Cantero G","year":"2023","unstructured":"Garrido-Cantero G, Longo F, Hern\u00e1ndez-Gonz\u00e1lez J, et al.. Impact of the COVID-19 pandemic on cancer diagnosis in Madrid (Spain) based on the RTMAD Tumor Registry (2019-2021). Cancers (Basel). 2023, 15:1753. 10.3390\/cancers15061753","journal-title":"Cancers (Basel)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01177-0","article-title":"COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)","volume":"14","author":"Pagano L","year":"2021","unstructured":"Pagano L, Salmanton-Garc\u00eda J, Marchesi F, et al.. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). J Hematol Oncol. 2021, 14:168. 10.1186\/s13045-021-01177-0","journal-title":"J Hematol Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102553","article-title":"Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022","volume":"71","author":"Salmanton-Garc\u00eda J","year":"2024","unstructured":"Salmanton-Garc\u00eda J, Marchesi F, Farina F, et al.. Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022. EClinicalMedicine. 2024, 71:102553. 10.1016\/j.eclinm.2024.102553","journal-title":"EClinicalMedicine"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280847","article-title":"COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)","volume":"108","author":"Marchesi F","year":"2023","unstructured":"Marchesi F, Salmanton-Garc\u00eda J, Emarah Z, et al.. COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA). Haematologica. 2023, 108:22-33. 10.3324\/haematol.2022.280847","journal-title":"Haematologica"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol28040269","article-title":"Evaluating the impact of the COVID-19 pandemic on new cancer diagnoses and oncology care in Manitoba","volume":"28","author":"Decker KM","year":"2021","unstructured":"Decker KM, Lambert P, Feely A, et al.. Evaluating the impact of the COVID-19 pandemic on new cancer diagnoses and oncology care in Manitoba. Curr Oncol. 2021, 28:3081-90. 10.3390\/curroncol28040269","journal-title":"Curr Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17937","article-title":"Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy","volume":"196","author":"Booth S","year":"2022","unstructured":"Booth S, Curley HM, Varnai C, et al.. Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy. Br J Haematol. 2022, 196:892-901. 10.1111\/bjh.17937","journal-title":"Br J Haematol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.70244","article-title":"COVID-19-related mortality in a real-world cohort of 18\u2009883 patients with premalignant and malignant haematological neoplasms: an analysis from the UK's Haematological Malignancy Research Network","volume":"208","author":"Smith A","year":"2026","unstructured":"Smith A, Frobisher C, Varghese A, et al.. COVID-19-related mortality in a real-world cohort of 18\u2009883 patients with premalignant and malignant haematological neoplasms: an analysis from the UK's Haematological Malignancy Research Network. Br J Haematol. 2026, 208:486-97. 10.1111\/bjh.70244","journal-title":"Br J Haematol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12020331","article-title":"Treatment-related risk factors for adverse outcomes of COVID-19 in patients treated for lymphoid malignancies in the pre-Omicron era - a study of KroHem, the Croatian Group for Hematologic Diseases","volume":"12","author":"Aurer I","year":"2024","unstructured":"Aurer I, Jak\u0161i\u0107 O, Ba\u0161i\u0107-Kinda S, et al.. Treatment-related risk factors for adverse outcomes of COVID-19 in patients treated for lymphoid malignancies in the pre-Omicron era - a study of KroHem, the Croatian Group for Hematologic Diseases. Biomedicines. 2024, 12:331. 10.3390\/biomedicines12020331","journal-title":"Biomedicines"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/508884-inpatient-hemato-oncology-service-use-before-during-and-after-covid-19-restrictions-in-a-romanian-tertiary-center","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:24:57Z","timestamp":1783664697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/508884-inpatient-hemato-oncology-service-use-before-during-and-after-covid-19-restrictions-in-a-romanian-tertiary-center"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.112380","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,9]]}}}